Cefadroxil 30 Antibiotic Disc – Biomaxima
Cefadroxil 30 Antibiotic Disk is a 6mm paper disc impregnated with 30 micrograms of cefadroxil. It is used in microbiological diagnostics to determine the susceptibility of bacteria to cefadroxil.
Cefadroxil is a first-generation cephalosporin antibiotic that is active against a wide range of bacteria, including Gram-positive bacteria such as Streptococcus pneumoniae and Staphylococcus aureus, and some Gram-negative bacteria such as Escherichia coli. It is used to treat a variety of infections, including upper respiratory infections, sinus infections, and urinary tract infections.
The Cefadroxil 30 Antibiotic Disk is manufactured by Biomaxima S.A., a pharmaceutical company based in Spain. It is available in packages of 50 or 100 discs.
Here are some of the important things to remember about Cefadroxil 30 Antibiotic Disk:
- It is for professional use only.
- It should be stored at 2-8 degrees Celsius.
- It should not be used if the expiration date has passed.
- It should be used according to the instructions provided by the manufacturer.
If you have any questions about Cefadroxil 30 Antibiotic Disk, you should consult with a healthcare professional.
Here is a table of the interpretation of the results of an antibiotic susceptibility test using the Cefadroxil 30 Antibiotic Disk:
| Zone of inhibition (mm) | Interpretation |
|---|---|
| ≥12 | Susceptible |
| 9-11 | Intermediate |
| ≤8 | Resistant |
Ease-of-use is provided by shatterproof spring-loaded cartridges, easy-to-read labeling and end-of-cartridge indicators.
disc diffusion not only categorizes resistant, intermediate and sensitive organisms through quantitative results but also provides a visual indication of the following:
- Inoculum level
- Presence of contamination
- Resistant mutants
- Beta-lactamase activity
- Antagonism and synergy between antibiotics
Each cartridge is individually sealed with a desiccant to maintain a moisture level of <2%, ensuring long term stability.












Reviews
There are no reviews yet.